Brief: Knight Announces Normal Course Issuer Bid
12/07/2023 13:01
July 12 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT ANNOUNCES NORMAL COURSE ISSUER BID
* KNIGHT THERAPEUTICS INC - PURSUANT TO NCIB, COMPANY
PROPOSES TO
PURCHASE OVER NEXT 12 MONTHS, UP TO ABOUT 6 MILLION COMMON
SHARES OF COMPANY
Source text for Eikon: ID:nGNX862mvk
Further company coverage: GUD.TO
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil